LYZ and cancer: LYZ expression over 2.0 (third quantile, round 1) and Paneth module scores over 0.2 (third quantile, round 2 to avoid getting 0) single cells were identified as LYZ+ cancer cells harboring Paneth cell properties, 1%, 13%, and 24% in normal, primary tumor, and metastasis samples, respectively.